Aimmune Therapeutics Inc AIMT:NASDAQ

Last Price$17.28Cboe Real-Time Last Sale as of 2:46PM ET 6/03/20
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.24(1.37%)
Bid (Size)$17.27 (6)
Ask (Size)$17.29 (100)
Day Low / High$16.97 - 17.83
Volume549.2 K

Insider Trends: Insider Buying Extended with Purchase of AIMSI Technologies Stock

5:05PM ET 3/19/2020 MT Newswires
Patrick G Enright, Director, made a purchase of 125,000 shares in AIMSI Technologies (AIMT) on Mar 17, 2020, for $1,420,045. After the Form 4 filing with the SEC, Enright has control over 6,183,695 company shares of which 70,561 shares are held directly and 6,113,134 are controlled indirectly. These holdings have an approximate market value of $71.2 million as of the prior-day closing price.

In the 90 days previous to the date of this filing, there have been 18 insider transactions reported to the SEC for AIMSI Technologies. These transactions came from the activities of 5 different insiders that resulted in a net acquisition of 54,245 company shares. In the preceding 90-day window of time, there were 2 transactions from 1 insider and resulted in no net change in insider holdings.

This level of insider transactions is lower than the peer group average in the 22-company Proprietary & Advanced Pharmaceuticals peer group over the last 90-day period. Activity in the peer group averaged 52.7 transactions per company, with company insiders acquiring on average 91,246 shares.

SEC Story Link